Cerebrospinal Fluid and Plasma Concentrations of Ubrogepant in Participants with a History of Migraine

Author:Boinpally, Ramesh   Trugman, Joel   

Session Name:P5: Headache: Advances in CGRP Inhibition 1  

Topic:Headache  

Program Number:P5.008  

Author Institution:AbbVie, North Chicago, IL  Abbvie, Moraga, CA  

Analysis of Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody and Antagonist Usage and Medication Switch Profile from a Tertiary Care Facility

Shift in MHDs below the threshold of preventive optimization after eptinezumab treatment in patients with migraine and history of 2–4 preventive migraine treatment failures